Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy



Summary

This research investigates the relationship between a “metabolic-immune score” and outcomes in advanced Non-Small Cell Lung Cancer (NSCLC) patients treated with immunotherapy. The score combines metabolic markers (like glucose and lipid metabolism) with immune factors to provide a comprehensive assessment of the tumor microenvironment. The study aims to determine if this score can predict which patients will respond better to immunotherapy and potentially identify those who might benefit from alternative or combined therapies. The findings could lead to personalized treatment strategies based on individual metabolic and immune profiles, ultimately improving survival rates and patient outcomes.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!